2025-07-23 - Analysis Report
Okay, here's a report analyzing Intuitive Surgical Inc. (ISRG) based on the provided data.

## ISRG Stock Analysis Report

**Ticker:** ISRG
**Company Name:** Intuitive Surgical Inc.
**Description:** Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

### 1. Performance vs. S&P 500 (VOO)

*   **ISRG Cumulative Return:** 117.62%
*   **VOO Cumulative Return:** 97.07%
*   **Absolute Deviation (ISRG - VOO):** 20.55%
*   **Deviation Range:** Max: 127.7, Min: -6.8
*   **Relative Deviation:** 20.8

**Analysis:** ISRG has outperformed the S&P 500 (VOO) with a cumulative return exceeding VOO by 20.55%.  The relative deviation of 20.8 indicates that the current outperformance is still relatively low, suggesting there is a lot of room for ISRG to grow.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|------|--------|
| 2015-2017  | 68.0%  | 56.5%  | 39.0% | 0.0  | 43.6   |
| 2016-2018  | 77.0%  | 63.4%  | 59.0% | 0.0  | 57.2   |
| 2017-2019  | 81.0%  | 63.4%  | 52.0% | 0.3  | 70.6   |
| 2018-2020  | 47.0%  | 63.4%  | 28.0% | 0.2  | 97.7   |
| 2019-2021  | 91.0%  | 63.0%  | 43.0% | 0.2  | 128.8  |
| 2020-2022  | -3.0%  | 69.9%  | -6.0% | 0.2  | 95.1   |
| 2021-2023  | -5.0%  | 72.9%  | -23.0% | 0.9  | 120.9  |
| 2022-2024  | 26.0%  | 72.9%  | 0.0%  | 0.9  | 187.1  |
| 2023-2025  | 38.0%  | 72.9%  | -11.0% | 0.7  | 183.2  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows significant growth in earlier periods (2015-2019), followed by weaker performance in recent years (2020-2023).  The most recent period (2023-2025) shows a rebound.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant price volatility and potential risk.
*   **Alpha:**  Alpha has decreased and even turned negative in recent periods, suggesting ISRG's performance is increasingly driven by market movements rather than independent factors.
*   **Beta:** Beta has increased in recent years, indicating that ISRG's stock is more sensitive to market movements than it has been in the past.

### 2. Recent Price Action

*   **Current Price:** 511.0
*   **Previous Close:** 516.12
*   **Change:** -0.99
*   **5-Day Moving Average:** 514.908
*   **20-Day Moving Average:** 525.4907
*   **60-Day Moving Average:** 533.4904

**Analysis:** The price has decreased slightly from the previous close. The price is below all moving averages, indicating a short-term downtrend.

### 3. Indicators & Expected Return

*   **MRI:** 0.3359 (Low Risk)
*   **RSI:** 29.11 (Oversold)
*   **PPO:** -0.2303
*   **Hybrid Signal:** cash_69%_Sell 69.7% of holdings (380 shares - Caution - MRI:0.35) (Cash Ratio: 69% on 2025-07-15)
*   **Delta Previous Relative Divergence (20-day):** -2.5 (Short-term decline)
*   **Expected Return:** 159.4% (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** The low MRI indicates a low-risk environment.
*   **RSI:** The RSI is below 30, indicating an oversold condition, which often precedes a price rebound.
*   **PPO:** The negative PPO value suggests that the stock's short-term moving average is below its long-term moving average, reinforcing the short-term downtrend.
*   **Hybrid Signal:** A cash holding of 69% indicates a strong cautious stance, emphasizing risk management.
*   **Delta Relative Divergence:** The negative divergence confirms the short-term downward trend.
*   **Expected Return:** The high expected return suggests significant potential outperformance compared to the S&P 500 over a long-term investment horizon. The contrast between the current downward pressure and high long-term expectations suggests a possible value opportunity, assuming the underlying business fundamentals remain strong.
*   **Price Change Impact:** The price change of -0.99 (-0.19%) from the previous close suggests no significant, immediate event driving extreme volatility.

### 4. Recent News & Significant Events

*   **2025-07-23:** Business developments, regulatory changes, or market events.
*   **2025-07-22:** Analyst discussions of recent performance in the context of industry and global economic factors.
*   **2025-07-21:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-19:** Market experts highlighting risks and opportunities, advising investors to monitor news and announcements.

**Analysis:**  The news suggests a period of significant activity around ISRG, with potential factors influencing the stock price. Investors should review the specific news items for a more detailed understanding of the developments.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2024-07-19 | 1.48 | 2.01 B$   |
| 2024-04-19 | 1.54 | 1.89 B$   |
| 2025-04-23 | 1.54 | 1.89 B$   |

**Analysis:** Both EPS and revenue show an upward trend over the analyzed quarters. The most recent EPS figure of $1.95 is notably strong. This indicates positive growth in profitability and sales.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31 | $2.25B   | 64.69%        |
| 2024-12-31 | $2.41B   | 68.04%        |
| 2024-09-30 | $2.04B   | 67.41%        |
| 2024-06-30 | $2.01B   | 68.30%        |
| 2024-03-31 | $1.89B   | 65.87%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-03-31 | $17.11B  | 4.08%  |
| 2024-12-31 | $16.43B  | 4.17%   |
| 2024-09-30 | $15.58B  | 3.63%   |
| 2024-06-30 | $14.71B  | 3.58%   |
| 2024-03-31 | $13.96B  | 3.90%  |

**Analysis:**

*   **Revenue:** Revenue is generally increasing, peaking in the most recent quarter. This indicates strong sales growth.
*   **Profit Margin:** Profit margins are consistently high, demonstrating strong operational efficiency and pricing power.
*   **Equity:** Equity is steadily increasing, reflecting the company's growing asset base.
*   **ROE:** ROE is relatively stable, indicating consistent profitability on shareholders' equity.

### 7. Overall Summary

Intuitive Surgical Inc. (ISRG) has demonstrated strong long-term outperformance compared to the S&P 500. Recent financial performance is positive, with growing revenue, high-profit margins, and increasing equity. However, recent price action indicates a short-term downtrend, with the stock price below key moving averages and an oversold RSI. Analyst discussions and news suggest the company is undergoing significant developments, with potential volatility.

**Investment Considerations:**

*   **Positive:** Strong financial performance, high expected return, dominant market position, potential oversold condition.
*   **Negative:** Short-term downtrend, high MDD, increasing Beta, recent negative Alpha.

**Recommendation:**

The Hybrid Signal suggests a cautious approach. While the long-term outlook remains positive, the current technical indicators suggest potential short-term downside. Further research into the recent news and analyst reports is recommended before making investment decisions. The high long-term expected return, coupled with a low-risk environment (MRI), suggests that ISRG may be a good long-term investment opportunity if current weakness persists, particularly for investors employing a dollar-cost averaging strategy.
